These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 660443)

  • 21. [Influence of the properties of the binding agent on the consistence of granulates (author's transl)].
    Ugri-Hunyadvári E
    Arch Pharm (Weinheim); 1975 Aug; 308(8):615-72. PubMed ID: 1190985
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of swelling of disintegrants on tablet disintegration (author's transl)].
    Nakai Y; Nakajima S; Fukuoka E
    Yakugaku Zasshi; 1977 Oct; 97(10):1058-63. PubMed ID: 592097
    [No Abstract]   [Full Text] [Related]  

  • 23. [Interactions between macromolecular adjuvants and drugs. Part 17: On the effect of macromolecular adjuvants on the dissolution rate of chlorpromazine from dosage forms (author's transl)].
    Voigt R; Gulde C; Sacher E
    Pharmazie; 1979; 34(3):168-71. PubMed ID: 450957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979; 34(3):164-7. PubMed ID: 450956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability study of Sumetrolim syrup.
    Arr M
    Ther Hung; 1983; 31(2):75-9. PubMed ID: 6336276
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmaceutical studies on physical properties of powders. V. Evaluation and estimation of flow properties of pharmaceutical mixed powders (author's transl)].
    Kigasawa K; Shimizu H; Iimura H; Watabe K; Koyama O
    Yakugaku Zasshi; 1977 Nov; 97(11):1159-67. PubMed ID: 616813
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of some binding agents on the mechanical properties of granules and their compression characteristics.
    Doelker E; Shotton E
    J Pharm Pharmacol; 1977 Apr; 29(4):193-8. PubMed ID: 17666
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro assays on the resorption of a drug (author's transl)].
    Telser E
    Dtsch Tierarztl Wochenschr; 1981 Jun; 88(6):231-5. PubMed ID: 7026212
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biopharmaceutical studies of drugs. V. Dissolution properties and bioavailability of ground mixtures of poorly water soluble drugs and soluble proteins (author's transl)].
    Kigasawa K; Maruyama K; Tanaka M; Watabe K; Koyama O
    Yakugaku Zasshi; 1981 Aug; 101(8):733-9. PubMed ID: 7328497
    [No Abstract]   [Full Text] [Related]  

  • 31. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 4th Part: Influence of the enteric polymer dissolution pH on the "in vivo" absorption of aspirin from coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(3):263-76. PubMed ID: 8603
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of adjuvants on the pharmaceutical and biological availability of chlorpromazine hydrochloride].
    Voigt R; Thomas G
    Pharmazie; 1983 Nov; 38(11):736-9. PubMed ID: 6669593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of the relative importance of formulation and process variables using factorial design.
    Sanderson IM; Kennerley JW; Parr GD
    J Pharm Pharmacol; 1984 Dec; 36(12):789-95. PubMed ID: 6151968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of lubricant during compaction of powders. Changes of compaction behaviours (author's transl)].
    Okada J; Hirai Y
    Yakugaku Zasshi; 1978 Nov; 98(10):1385-90. PubMed ID: 745045
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems concerning the optimal use of celluloses as adjuvants in tabletting. 2. Insertion characteristics of certain adjuvants with the use of regression models].
    Moldenhauer H; Loh HJ
    Pharmazie; 1978 Apr; 33(4):216-21. PubMed ID: 674318
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the development of oral preparations of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
    Dechow HJ; Dölcher D; Hübner G; Kim S; Lämmerhirt K; Pich CH; Schmidt-Böthelt E
    Arzneimittelforschung; 1976; 26(42):596-613. PubMed ID: 947320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the effect of some pharmaceutic aids on the physical properties of tablets].
    Sümegi G; Kedvessy G
    Pharmazie; 1970 Sep; 25(9):544-6. PubMed ID: 5486682
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro studies on the interactions between active ingredients and adjuvants].
    Stampf
    Pharmazie; 1978 Jul; 33(7):447-50. PubMed ID: 724764
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmaceutical studies on physical properties of powders. IV. Study on the estimation of flow rate through horizontal circular orifice (author's transl)].
    Kigazawa K; Iimura H; Watabe K
    Yakugaku Zasshi; 1974 Jan; 94(1):88-92. PubMed ID: 4859052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.